Clinical outcome of a protocol to produce immunosuppression in rhesus monkeys (Macaca mulatta): application to infectious disease and gene therapy studies.
Induced immunosuppression is required for a number of studies using rhesus monkeys (Macaca mulatta). This report describes the clinical outcome and safety of a dose-finding experiment that determined doses of cyclophosphamide and prednisone that could be used to induce a state of immunosuppression in rhesus monkeys. After determining the optimum dose of immunosuppressive agents, the protocol was then used on animals participating in infectious disease and gene therapy studies. Splenectomy was performed in some animals to increase the severity of immunosuppression. The onset, duration, and severity of lymphopenia and leukopenia were consistent in all animals. In most animals, physical examination findings and clinical serum chemistry profiles demonstrated only transient abnormalities. With proper clinical monitoring, combination treatment with cyclophosphamide and prednisone is an effective and safe method for inducing immunosuppression in rhesus monkeys.
Bohm
R P
RP
Department of Veterinary Medicine, Tulane Regional Primate Research Center, Covington, LA 70433, USA.
Dennis
V
V
Blanchard
J L
JL
Philipp
M T
MT
Gerber
M A
MA
D000818:Animals; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000494:pharmacology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015316:Genetic Therapy; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000494:pharmacology; D007970:Leukopenia; D008253:Macaca mulatta / Q000276:immunology; D011241:Prednisone / Q000008:administration & dosage* / Q000494:pharmacology; D012107:Research Design
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone